This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrison, B. C.
Right arrow Articles by McKinsey, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, B. C.
Right arrow Articles by McKinsey, T. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2004, p. 10636-10649, Vol. 24, No. 24
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.24.10636-10649.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression

Brooke C. Harrison, Charles R. Roberts, David B. Hood, Meghan Sweeney, Jody M. Gould, Erik W. Bush, and Timothy A. McKinsey*

Myogen, Inc., Westminster, Colorado

Received 19 May 2004/ Returned for modification 6 July 2004/ Accepted 7 September 2004

Diverse pathological insults trigger a cardiac remodeling process during which myocytes undergo hypertrophy, with consequent decline in cardiac function and eventual heart failure. Multiple transcriptional regulators of pathological cardiac hypertrophy are controlled at the level of subcellular distribution. For example, prohypertrophic transcription factors belonging to the nuclear factor of activated T cells (NFAT) and GATA families are subject to CRM1-dependent nuclear export but are rapidly relocalized to the nucleus in response to cues for hypertrophic growth. Here, we demonstrate that the antihypertrophic chromatin-modifying enzyme histone deacetylase 5 (HDAC5) is shuttled out of the cardiomyocyte nucleus via a CRM1-mediated pathway in response to diverse signals for hypertrophy. CRM1 antagonists block the agonist-mediated nuclear export of HDAC 5 and repress pathological gene expression and associated hypertrophy of cultured cardiomyocytes. Conversely, CRM1 activity is dispensable for nonpathological cardiac gene activation mediated by thyroid hormone and insulin-like growth factor 1, agonists that fail to trigger the nuclear export of HDAC5. These results suggest a selective role for CRM1 in derepression of pathological cardiac genes via its neutralizing effects on antihypertrophic factors such as HDAC5. Pharmacological approaches targeting CRM1-dependent nuclear export in heart muscle may have salutary effects on cardiac function by suppressing maladaptive changes in gene expression evoked by stress signals.

* Corresponding author. Mailing address: Myogen, Inc., 7575 W. 103rd Ave., Westminister, CO 80021. Phone: (303) 533-1736. Fax: (303) 410-6669. E-mail: timothy.mckinsey{at}myogen.com.

Molecular and Cellular Biology, December 2004, p. 10636-10649, Vol. 24, No. 24
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.24.10636-10649.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Liu, Y., Contreras, M., Shen, T., Randall, W. R., Schneider, M. F. (2009). {alpha}-Adrenergic signalling activates protein kinase D and causes nuclear efflux of the transcriptional repressor HDAC5 in cultured adult mouse soleus skeletal muscle fibres. J. Physiol. 587: 1101-1115 [Abstract] [Full Text]  
  • Jensen, E. D., Gopalakrishnan, R., Westendorf, J. J. (2009). Bone Morphogenic Protein 2 Activates Protein Kinase D to Regulate Histone Deacetylase 7 Localization and Repression of Runx2. J. Biol. Chem. 284: 2225-2234 [Abstract] [Full Text]  
  • Sucharov, C. C., Dockstader, K., McKinsey, T. A. (2008). YY1 Protects Cardiac Myocytes from Pathologic Hypertrophy by Interacting with HDAC5. Mol. Biol. Cell 19: 4141-4153 [Abstract] [Full Text]  
  • Xu, X., Ha, C.-H., Wong, C., Wang, W., Hausser, A., Pfizenmaier, K., Olson, E. N., McKinsey, T. A., Jin, Z.-G. (2007). Angiotensin II Stimulates Protein Kinase D-Dependent Histone Deacetylase 5 Phosphorylation and Nuclear Export Leading to Vascular Smooth Muscle Cell Hypertrophy. Arterioscler. Thromb. Vasc. Bio. 27: 2355-2362 [Abstract] [Full Text]  
  • Takaoka, Y., Ohta, M., Ito, A., Takamatsu, K., Sugano, A., Funakoshi, K., Takaoka, N., Sato, N., Yokozaki, H., Arizono, N., Goto, S., Maeda, E. (2007). Electroacupuncture suppresses myostatin gene expression: cell proliferative reaction in mouse skeletal muscle. Physiol. Genomics 30: 102-110 [Abstract] [Full Text]  
  • McKinsey, T. A. (2007). Derepression of pathological cardiac genes by members of the CaM kinase superfamily. Cardiovasc Res 73: 667-677 [Abstract] [Full Text]  
  • Bush, E. W., Hood, D. B., Papst, P. J., Chapo, J. A., Minobe, W., Bristow, M. R., Olson, E. N., McKinsey, T. A. (2006). Canonical Transient Receptor Potential Channels Promote Cardiomyocyte Hypertrophy through Activation of Calcineurin Signaling. J. Biol. Chem. 281: 33487-33496 [Abstract] [Full Text]  
  • Sucharov, C. C., Langer, S., Bristow, M., Leinwand, L. (2006). Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A. Am. J. Physiol. Cell Physiol. 291: C1029-C1037 [Abstract] [Full Text]  
  • Sucharov, C. C., Mariner, P. D., Nunley, K. R., Long, C., Leinwand, L., Bristow, M. R. (2006). A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol. Heart Circ. Physiol. 291: H1299-H1308 [Abstract] [Full Text]  
  • Harrison, B. C., Kim, M.-S., van Rooij, E., Plato, C. F., Papst, P. J., Vega, R. B., McAnally, J. A., Richardson, J. A., Bassel-Duby, R., Olson, E. N., McKinsey, T. A. (2006). Regulation of Cardiac Stress Signaling by Protein Kinase D1. Mol. Cell. Biol. 26: 3875-3888 [Abstract] [Full Text]  
  • Backs, J., Olson, E. N. (2006). Control of Cardiac Growth by Histone Acetylation/Deacetylation. Circ. Res. 98: 15-24 [Abstract] [Full Text]  
  • McKinsey, T. A., Kuwahara, K., Bezprozvannaya, S., Olson, E. N. (2006). Class II Histone Deacetylases Confer Signal Responsiveness to the Ankyrin-Repeat Proteins ANKRA2 and RFXANK. Mol. Biol. Cell 17: 438-447 [Abstract] [Full Text]  
  • Yang, X.-J., Gregoire, S. (2005). Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication. Mol. Cell. Biol. 25: 2873-2884 [Full Text]  
  • Liu, Y., Randall, W. R., Schneider, M. F. (2005). Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle. JCB 168: 887-897 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»